CSL LIMITED - Announcements

1.13%

$263.82

Market Cap $127.7B

Healthcare Biotechnology

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

CSL	CSL Notice of 2019 Annual General Meeting		06/09/19	1.1MB	Share
CSL	CSL Annual Report 2018/19		06/09/19	6.44MB	Share
CSL	Change of Director's Interest Notice		30/08/19	107.91KB	Share
CSL	Change of Director's Interest Notice		30/08/19	179.71KB	Share
CSL	Appendix 3B		27/08/19	160.26KB	Share
CSL	Change of Director's Interest Notice		23/08/19	211.61KB	Share
CSL	Update - Dividend/Distribution - CSL		14/08/19	31.93KB	Share
CSL	Dividend/Distribution - CSL		14/08/19	31.83KB	Share
CSL	CSL Results Presentation	PRICE SENSITIVE	14/08/19	2.96MB	Share
CSL	CSL Results Announcement	PRICE SENSITIVE	14/08/19	250.15KB	Share
CSL	CSL Full Year Statutory Accounts for the Year Ended 30/06/19	PRICE SENSITIVE	14/08/19	2.88MB	Share
CSL	Notice of 2019 Full Year Result meeting		06/08/19	237.45KB	Share
CSL	Anjana Narain to Lead Seqirus Influenza Vaccines Business		17/07/19	238.26KB	Share
CSL	UPDATE ON CSL TRANSITION TO OWN DISTRIBUTOR MODEL IN CHINA	PRICE SENSITIVE	21/06/19	177.08KB	Share
CSL	Appendix 3B		04/06/19	340.39KB	Share
CSL	Shareholder Information Meetings		28/05/19	2.51MB	Share
CSL	Appointmet of Chief Operating Officer		16/05/19	103.94KB	Share
CSL	Appendix 3B		14/05/19	497.43KB	Share
CSL	Notice of Shareholder Information Meetings		08/05/19	103.94KB	Share
CSL	Seqirus Presentation at 2019 Macquarie Equities Conference		30/04/19	1.86MB	Share
CSL	Appendix 3B		02/04/19	297.78KB	Share
CSL	Appendix 3B		12/03/19	346.04KB	Share
CSL	Change of Director's Interest Notice		21/02/19	629.99KB	Share
CSL	Update - Dividend/Distribution - CSL		20/02/19	31.91KB	Share
CSL	Appendix 3B		19/02/19	332.5KB	Share
CSL	Dividend/Distribution - CSL		13/02/19	31.77KB	Share
CSL	Half Year Results Analyst Presentation	PRICE SENSITIVE	13/02/19	2.6MB	Share
CSL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	13/02/19	889.89KB	Share
CSL	Notice of Investor/Analyst Briefing - Half Year Results 2019		06/02/19	238.64KB	Share
CSL	Appendix 3B		29/01/19	486.99KB	Share
CSL	2019 JP Morgan Healthcare Conference		10/01/19	1.22MB	Share
CSL	CSL R&D Investor Briefing	PRICE SENSITIVE	05/12/18	4.19MB	Share
CSL	Notice of Research & Development Investor Briefing		30/11/18	121.54KB	Share
CSL	Becoming a substantial holder		05/11/18	615.7KB	Share
CSL	Change of Director's Interest Notice		01/11/18	359.51KB	Share
CSL	Final Director's Interest Notice		22/10/18	292.02KB	Share
CSL	Final Director's Interest Notice		22/10/18	292.43KB	Share
CSL	Initial Director's Interest Notice		22/10/18	293.37KB	Share
CSL	Change of Director's Interest Notice		19/10/18	296.86KB	Share
CSL	Results of Meeting		17/10/18	191.9KB	Share
CSL	CSL Chairmans Address and CEOs Presentation		17/10/18	2.2MB	Share
CSL	Appendix 3B		25/09/18	480.14KB	Share
CSL	Change of Director's Interest Notice		21/09/18	365.92KB	Share
CSL	Appendix 4G - Key to Disclosures		14/09/18	822.21KB	Share
CSL	CSL Annual Report to shareholders		14/09/18	5.53MB	Share
CSL	Notice of Annual General Meeting/Proxy Form		14/09/18	979.09KB	Share
CSL	Change of Director's Interest Notice		07/09/18	367.11KB	Share
CSL	Appendix 3B		04/09/18	487.49KB	Share
CSL	Change of Director's Interest Notice		27/08/18	600.52KB	Share
CSL	Notice of Annual General Meeting		24/08/18	1.16MB	Share
CSL	Change of Director's Interest Notice		17/08/18	648.21KB	Share
CSL	Full Year Results Presentation		15/08/18	1.94MB	Share
CSL	Full Year Results Announcement	PRICE SENSITIVE	15/08/18	183.69KB	Share
CSL	Dividend/Distribution - CSL		15/08/18	31.77KB	Share
CSL	Full Year Statutory Accounts	PRICE SENSITIVE	15/08/18	1.12MB	Share
CSL	Notice of Investor and Analyst Briefing 2018 FY Results		08/08/18	238.13KB	Share
CSL	Appendix 3B		03/07/18	183.43KB	Share
CSL	Appendix 3B		22/05/18	590.46KB	Share
CSL	CSL Lifts Profit Guidance	PRICE SENSITIVE	18/05/18	400.28KB	Share
CSL	Change of Director's Interest Notice		10/05/18	50.26KB	Share
CSL	Appointment of Company Secretary		19/04/18	77.21KB	Share
CSL	Appendix 3B		20/03/18	138.26KB	Share
CSL	Appendix 3B		27/02/18	134.37KB	Share
CSL	Change of Director's Interest Notice		16/02/18	461.29KB	Share
CSL	Initial Director's Interest Notice		16/02/18	17.18KB	Share
CSL	Initial Director's Interest Notice		16/02/18	16.71KB	Share
CSL	Half Year Results Analyst Presentation		14/02/18	557.8KB	Share
CSL	Dividend/Distribution - CSL		14/02/18	31.77KB	Share
CSL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	14/02/18	289.9KB	Share
CSL	Notice of Investor/Analyst Briefing - 2018 Half Year Results		06/02/18	48.22KB	Share
CSL	Company Secretary Appointment/Resignation		21/12/17	62.41KB	Share
CSL	CSL Appoints New Directors		13/12/17	57.11KB	Share
CSL	Appendix 3B		05/12/17	396.02KB	Share
CSL	R&D Investor Briefing		05/12/17	2.29MB	Share
CSL	PGC: Acquisition of Immunohaematology Business	PRICE SENSITIVE	01/12/17	609.86KB	Share
CSL	Notice of Research & Development Investor Briefing		30/11/17	80.1KB	Share
CSL	Appendix 3B		14/11/17	395.95KB	Share
CSL	Appendix 3B		24/10/17	134.99KB	Share
CSL	Change of Director's Interest Notice		20/10/17	43.2KB	Share
CSL	Final Director's Interest Notice Appendix 3Z		18/10/17	17.97KB	Share
CSL	Results of 2017 Annual General Meeting		18/10/17	77.52KB	Share
CSL	CEO's AGM Presentation	PRICE SENSITIVE	18/10/17	1.04MB	Share
CSL	Chairman's Address to Shareholders		18/10/17	65.7KB	Share
CSL	New Debt Facilities	PRICE SENSITIVE	05/10/17	103.3KB	Share
CSL	Change to Company Details		15/09/17	712.02KB	Share
CSL	FDA Approves Privigen for CIDP Indication	PRICE SENSITIVE	15/09/17	54.68KB	Share
CSL	Retirement of Director		15/09/17	42.44KB	Share
CSL	Annual Report to Shareholders		15/09/17	5.43MB	Share
CSL	Notice of AGM/Proxy Form & Shareholder Questions		15/09/17	4.21MB	Share
CSL	Appendix 4G - Key to Disclosures		15/09/17	79.12KB	Share
CSL	Appendix 3B (Amended)		13/09/17	194.98KB	Share
CSL	Appendix 3B		12/09/17	135.32KB	Share
CSL	Final share buy-back notice - Appendix 3F		05/09/17	363.17KB	Share
CSL	Final share buy-back notice - Appendix 3F		05/09/17	239.78KB	Share
CSL	Daily share buy-back notice - Appendix 3E		05/09/17	12.13KB	Share
CSL	Daily share buy-back notice - Appendix 3E		04/09/17	9.12KB	Share
CSL	Change of Director's Interest Notice		01/09/17	403.65KB	Share
CSL	Daily share buy-back notice - Appendix 3E		01/09/17	12.14KB	Share
CSL	Daily share buy-back notice - Appendix 3E		31/08/17	12.14KB	Share
CSL	Daily share buy-back notice - Appendix 3E		30/08/17	12.14KB	Share

CSL CSL Notice of 2019 Annual General Meeting
06/09/19		1.1MB	Share
CSL CSL Annual Report 2018/19
06/09/19		6.44MB	Share
CSL Change of Director's Interest Notice
30/08/19		107.91KB	Share
CSL Change of Director's Interest Notice
30/08/19		179.71KB	Share
CSL Appendix 3B
27/08/19		160.26KB	Share
CSL Change of Director's Interest Notice
23/08/19		211.61KB	Share
CSL Update - Dividend/Distribution - CSL
14/08/19		31.93KB	Share
CSL Dividend/Distribution - CSL
14/08/19		31.83KB	Share
CSL CSL Results Presentation
14/08/19	PRICE SENSITIVE	2.96MB	Share
CSL CSL Results Announcement
14/08/19	PRICE SENSITIVE	250.15KB	Share
CSL CSL Full Year Statutory Accounts for the Year Ended 30/06/19
14/08/19	PRICE SENSITIVE	2.88MB	Share
CSL Notice of 2019 Full Year Result meeting
06/08/19		237.45KB	Share
CSL Anjana Narain to Lead Seqirus Influenza Vaccines Business
17/07/19		238.26KB	Share
CSL UPDATE ON CSL TRANSITION TO OWN DISTRIBUTOR MODEL IN CHINA
21/06/19	PRICE SENSITIVE	177.08KB	Share
CSL Appendix 3B
04/06/19		340.39KB	Share
CSL Shareholder Information Meetings
28/05/19		2.51MB	Share
CSL Appointmet of Chief Operating Officer
16/05/19		103.94KB	Share
CSL Appendix 3B
14/05/19		497.43KB	Share
CSL Notice of Shareholder Information Meetings
08/05/19		103.94KB	Share
CSL Seqirus Presentation at 2019 Macquarie Equities Conference
30/04/19		1.86MB	Share
CSL Appendix 3B
02/04/19		297.78KB	Share
CSL Appendix 3B
12/03/19		346.04KB	Share
CSL Change of Director's Interest Notice
21/02/19		629.99KB	Share
CSL Update - Dividend/Distribution - CSL
20/02/19		31.91KB	Share
CSL Appendix 3B
19/02/19		332.5KB	Share
CSL Dividend/Distribution - CSL
13/02/19		31.77KB	Share
CSL Half Year Results Analyst Presentation
13/02/19	PRICE SENSITIVE	2.6MB	Share
CSL Appendix 4D and Half Year Accounts
13/02/19	PRICE SENSITIVE	889.89KB	Share
CSL Notice of Investor/Analyst Briefing - Half Year Results 2019
06/02/19		238.64KB	Share
CSL Appendix 3B
29/01/19		486.99KB	Share
CSL 2019 JP Morgan Healthcare Conference
10/01/19		1.22MB	Share
CSL CSL R&D Investor Briefing
05/12/18	PRICE SENSITIVE	4.19MB	Share
CSL Notice of Research & Development Investor Briefing
30/11/18		121.54KB	Share
CSL Becoming a substantial holder
05/11/18		615.7KB	Share
CSL Change of Director's Interest Notice
01/11/18		359.51KB	Share
CSL Final Director's Interest Notice
22/10/18		292.02KB	Share
CSL Final Director's Interest Notice
22/10/18		292.43KB	Share
CSL Initial Director's Interest Notice
22/10/18		293.37KB	Share
CSL Change of Director's Interest Notice
19/10/18		296.86KB	Share
CSL Results of Meeting
17/10/18		191.9KB	Share
CSL CSL Chairmans Address and CEOs Presentation
17/10/18		2.2MB	Share
CSL Appendix 3B
25/09/18		480.14KB	Share
CSL Change of Director's Interest Notice
21/09/18		365.92KB	Share
CSL Appendix 4G - Key to Disclosures
14/09/18		822.21KB	Share
CSL CSL Annual Report to shareholders
14/09/18		5.53MB	Share
CSL Notice of Annual General Meeting/Proxy Form
14/09/18		979.09KB	Share
CSL Change of Director's Interest Notice
07/09/18		367.11KB	Share
CSL Appendix 3B
04/09/18		487.49KB	Share
CSL Change of Director's Interest Notice
27/08/18		600.52KB	Share
CSL Notice of Annual General Meeting
24/08/18		1.16MB	Share
CSL Change of Director's Interest Notice
17/08/18		648.21KB	Share
CSL Full Year Results Presentation
15/08/18		1.94MB	Share
CSL Full Year Results Announcement
15/08/18	PRICE SENSITIVE	183.69KB	Share
CSL Dividend/Distribution - CSL
15/08/18		31.77KB	Share
CSL Full Year Statutory Accounts
15/08/18	PRICE SENSITIVE	1.12MB	Share
CSL Notice of Investor and Analyst Briefing 2018 FY Results
08/08/18		238.13KB	Share
CSL Appendix 3B
03/07/18		183.43KB	Share
CSL Appendix 3B
22/05/18		590.46KB	Share
CSL CSL Lifts Profit Guidance
18/05/18	PRICE SENSITIVE	400.28KB	Share
CSL Change of Director's Interest Notice
10/05/18		50.26KB	Share
CSL Appointment of Company Secretary
19/04/18		77.21KB	Share
CSL Appendix 3B
20/03/18		138.26KB	Share
CSL Appendix 3B
27/02/18		134.37KB	Share
CSL Change of Director's Interest Notice
16/02/18		461.29KB	Share
CSL Initial Director's Interest Notice
16/02/18		17.18KB	Share
CSL Initial Director's Interest Notice
16/02/18		16.71KB	Share
CSL Half Year Results Analyst Presentation
14/02/18		557.8KB	Share
CSL Dividend/Distribution - CSL
14/02/18		31.77KB	Share
CSL Appendix 4D and Half Year Accounts
14/02/18	PRICE SENSITIVE	289.9KB	Share
CSL Notice of Investor/Analyst Briefing - 2018 Half Year Results
06/02/18		48.22KB	Share
CSL Company Secretary Appointment/Resignation
21/12/17		62.41KB	Share
CSL CSL Appoints New Directors
13/12/17		57.11KB	Share
CSL Appendix 3B
05/12/17		396.02KB	Share
CSL R&D Investor Briefing
05/12/17		2.29MB	Share
CSL PGC: Acquisition of Immunohaematology Business
01/12/17	PRICE SENSITIVE	609.86KB	Share
CSL Notice of Research & Development Investor Briefing
30/11/17		80.1KB	Share
CSL Appendix 3B
14/11/17		395.95KB	Share
CSL Appendix 3B
24/10/17		134.99KB	Share
CSL Change of Director's Interest Notice
20/10/17		43.2KB	Share
CSL Final Director's Interest Notice Appendix 3Z
18/10/17		17.97KB	Share
CSL Results of 2017 Annual General Meeting
18/10/17		77.52KB	Share
CSL CEO's AGM Presentation
18/10/17	PRICE SENSITIVE	1.04MB	Share
CSL Chairman's Address to Shareholders
18/10/17		65.7KB	Share
CSL New Debt Facilities
05/10/17	PRICE SENSITIVE	103.3KB	Share
CSL Change to Company Details
15/09/17		712.02KB	Share
CSL FDA Approves Privigen for CIDP Indication
15/09/17	PRICE SENSITIVE	54.68KB	Share
CSL Retirement of Director
15/09/17		42.44KB	Share
CSL Annual Report to Shareholders
15/09/17		5.43MB	Share
CSL Notice of AGM/Proxy Form & Shareholder Questions
15/09/17		4.21MB	Share
CSL Appendix 4G - Key to Disclosures
15/09/17		79.12KB	Share
CSL Appendix 3B (Amended)
13/09/17		194.98KB	Share
CSL Appendix 3B
12/09/17		135.32KB	Share
CSL Final share buy-back notice - Appendix 3F
05/09/17		363.17KB	Share
CSL Final share buy-back notice - Appendix 3F
05/09/17		239.78KB	Share
CSL Daily share buy-back notice - Appendix 3E
05/09/17		12.13KB	Share
CSL Daily share buy-back notice - Appendix 3E
04/09/17		9.12KB	Share
CSL Change of Director's Interest Notice
01/09/17		403.65KB	Share
CSL Daily share buy-back notice - Appendix 3E
01/09/17		12.14KB	Share
CSL Daily share buy-back notice - Appendix 3E
31/08/17		12.14KB	Share
CSL Daily share buy-back notice - Appendix 3E
30/08/17		12.14KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $263.82		Change 2.940(1.13%)		Mkt cap ! $127.7B

Open	High	Low	Value	Volume
$262.44	$263.85	$260.65	$114.6M	435.5K

Buyers (Bids)

No.	Vol.	Price($)
1	30	$263.40

Sellers (Offers)

Price($)	Vol.	No.
$263.82	828	2

View Market Depth

No.	Vol.	Price($)
1	30	263.400
1	37	263.290
1	7	263.020
1	50	262.800
1	2434	262.710

Price($)	Vol.	No.
263.880	201	2
263.960	50	1
263.970	336	1
264.000	1823	3
264.080	2404	1

Last trade - 16.10pm 11/08/2025 (20 minute delay)

CSL (ASX) Chart

CSL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories